Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00586326 · ClinicalTrials.gov registry record · Phase 2
MammoSite as Sole Radiation Therapy Technique for Ductal Carcinoma In-Situ
A Phase 2 study, sponsored by Hologic.
- Completed
- Registry status
- Phase 2
- Development phase
- 133
- Enrollment target
NCT00586326 is a Phase 2 study that has completed, run by Hologic. The registered enrollment target is 133 participants.
The verdict
NCT00586326, a Phase 2 study, has completed, sponsored by Hologic.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 133 participants
- Enrollment target
Study Summary
This study has been designed to compile information on the efficacy of the MammoSite RTS providing sole radiation therapy for patients with pure DCIS.
Interventions
- DEVICE MammoSite Radiation Therapy System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 133 participants |
| Start Date | 2003-08 |
| Est. Completion | 2011-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00586326
The ClinicalTrials.gov registry entry for NCT00586326 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 133 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hologic, which has 21 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MammoSite Radiation Therapy System is the first listed.
NCT00586326 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00586326 about?
NCT00586326 is a clinical study titled "MammoSite as Sole Radiation Therapy Technique for Ductal Carcinoma In-Situ". This study has been designed to compile information on the efficacy of the MammoSite RTS providing sole radiation therapy for patients with pure DCIS.
What is the current status of trial NCT00586326?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 133 participants. The study started on 2003-08. Estimated completion is 2011-04.
What interventions are being tested in trial NCT00586326?
The interventions under investigation include: MammoSite Radiation Therapy System (DEVICE).
Who is sponsoring clinical trial NCT00586326?
This trial is sponsored by Hologic, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.